• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Thursday, February 19, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News

Researchers develop a simplified method to modify disease signaling with light

Bioengineer by Bioengineer
October 22, 2020
in Science News
Reading Time: 2 mins read
0
IMAGE
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

IMAGE

Credit: Michael Courtney

Most diseases are caused by aberrant cell signaling processes and basic research in cell signaling is needed to identify targets for future therapeutic approaches, especially in cases where no cures or effective treatments are currently available.

Cellular optogenetics uses light to precisely control cell signaling in space and over time, making it an invaluable technique for disease research. However, this potentially revolutionary method has been difficult for many researchers to use as, over long periods of time, the used light can itself have adverse effects on biological systems and the optogenetic tools can inactivate unexpectedly rapidly.

Now, researchers from the University of Turku in Finland, in collaboration with Frankfurt University Hospital in Germany, have developed a novel way to harness the quantum mechanical phenomenon of resonance energy transfer to design optogenetic tools that are more sensitive to light. The new method also informs the user exactly when an optogenetic tool is going to inactivate in cells. If continued activity is required, just the right amount of additional light can then be re-applied to re-activate the tool.

Combining these advances with existing tools and knowledge, the researchers were able to design and build more efficient optogenetic tools to investigate signaling pathways. With the improved tools, they studied two common chemotherapy drugs known to cause side effects on neurons and cause neuropathic pain. The new tools revealed how both activatory and inhibitory pathways contribute to the actions of these drugs on the investigated disease-associated pathway.

“Now we can develop more powerful tools to understand precisely how harmful conditions disrupt signaling in living cells. This information is likely to help us in identifying targets and designing better therapeutic compounds for conditions such as chemotherapy-induced neuropathic pain,” says Lili Li, the lead author of the study and Postdoctoral Researcher at the Turku Bioscience Centre.

“There is still considerable potential to further exploit these quantum mechanical phenomena to devise even better quantitative and informative methods in biology and medicine, which could support the future discovery of new therapeutic approaches,” adds senior author of the study Michael Courtney.

###

Media Contact
Michael Courtney
[email protected]

Original Source

https://www.utu.fi/en/news/press-release/researchers-develop-a-simplified-method-to-modify-disease-signaling-with-light

Related Journal Article

http://dx.doi.org/10.1038/s41467-020-18816-8

Tags: BiotechnologycancerDiagnosticsMedicine/Health
Share12Tweet8Share2ShareShareShare2

Related Posts

Millions Unaware That Heart Risks Often Originate Outside the Heart

February 19, 2026

Satellite Imagery and AI Uncover Development Gaps Masked by National Data

February 19, 2026

Medicare Advantage Beneficiaries Face Involuntary Disenrollment After 2026 Plan Exits

February 19, 2026

AI-Driven ECG Technology Promises Enhanced Lifelong Heart Monitoring for Patients with Repaired Tetralogy of Fallot

February 19, 2026
Please login to join discussion

POPULAR NEWS

  • Imagine a Social Media Feed That Challenges Your Views Instead of Reinforcing Them

    Imagine a Social Media Feed That Challenges Your Views Instead of Reinforcing Them

    944 shares
    Share 376 Tweet 235
  • Digital Privacy: Health Data Control in Incarceration

    64 shares
    Share 26 Tweet 16
  • New Record Great White Shark Discovery in Spain Prompts 160-Year Scientific Review

    59 shares
    Share 24 Tweet 15
  • Epigenetic Changes Play a Crucial Role in Accelerating the Spread of Pancreatic Cancer

    56 shares
    Share 22 Tweet 14

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

AI-Driven ECG Technology Promises Enhanced Lifelong Heart Monitoring for Patients with Repaired Tetralogy of Fallot

Mindfulness Practices Significantly Alleviate Depression Symptoms, Particularly in Individuals with Early-Life Adversity

Professor Tae-Woo Lee’s Team Pioneers Mass Production Technology for Ultra-High Color Purity Perovskite Emitters

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 74 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.